5 completed, 1 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 1 | Unknown 1 |
Follow ISDIN: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Eryfotona AK-NMSC® cream, Sunscreen SPF 50+ - Actinic Keratosis | Phase 4 | Unknown | ISDIN | 50 | 2012-07-01 | 2013-10-11 |
| Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal Lambdalina® (Lidocaine 4% cream), Placebo - Local Anesthesia | Phase 2 | Completed | ISDIN | 42 | 2011-05-01 | 2012-04-13 |
| Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study P144 cream - Skin Fibrosis | Phase 2 | Completed | ISDIN | 38 | 2008-07-01 | 2013-02-11 |
| Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test Ciclosporin 0.5% (Formulation 01B), Ciclosporin 1.5% (Formulation 02B), 0.1% betamethasone - Psoriasis | Phase 1 / Phase 2 | Completed | ISDIN | 25 | 2007-11-01 | 2008-11-05 |
| Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis P144, placebo - Skin Fibrosis | Phase 2 | Completed | ISDIN | 56 | 2007-09-01 | 2013-02-11 |
| Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers P144 cream, Placebo - Healthy | Phase 1 | Completed | ISDIN | 36 | 2007-03-01 | 2008-11-05 |
Scleroderma, Systemic (3) · Agnosia (1) · Keratosis, Actinic (1) · Psoriasis (1)
Betamethasone (1) · Cyclosporine (1) · Lidocaine (1) · calcipotriene (1)
Spain (4) · Germany (3) · Italy (3) · Hungary (2) · Poland (2) · United Kingdom (2)
Antonio Campo Voegeli, MD (1) · Christopher Denton, MD (1) · Dr. Giuseppe Argenziano,, MD, PhD (1) · Johannes Gassmueller, MD (1) · Marco Matucci, MD (1) · Marco Matucci, MD, PhD (1) · Thomas Krieg, MD (1)
2008 (1)